Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.
Aliment Pharmacol Ther 18(4):395-400 (2003) PMID 12940924
Azathioprine and mercaptopurine (MP) are well established treatments for inflammatory bowel disease but they have severe adverse effects that prevent their use in some patients. The likelihood and type of adverse effect may relate to thiopurine methyltransferase (TPMT) enzyme activity and genotype.
DOI: 10.1046/j.1365-2036.2003.01690.x
Version: za2963e q8za9 q8zb3 q8zc9 q8zd4 q8ze5 q8zf0 q8zg5